Chlamydia pneumoniae infection and restenosis in patients with coronary heart disease

Infection

Volumn 31, Issue 3, 2003, Pages 149-154

  Krausse, Rea ^a   Leiendecker, J ^a   Herrmann, Gunhild ^a   Harder, T ^a   Ullmann, U ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN A;

ADULT; AGED; ANAMNESIS; ANGIOCARDIOGRAPHY; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIUM DETECTION; BLOOD ANALYSIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENUS; HUMAN; IMMUNOFLUORESCENCE TEST; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OROPHARYNX; PATIENT SELECTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POLYMERASE CHAIN REACTION; RESTENOSIS; SENESCENCE; SEROLOGY; SERUM; SMOKING;

EID: 0037777805     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-003-3056-y     Document Type: Article

References (37)

1. Grayston JT, Kuo CC, Campbell LA, Wang SP: Chlamydia pneumoniae sp. Nov. for Chlamydia sp. strain TWAR. Int J Syst Bacteriol 1989; 39: 88-90.
2. Hahn DL, Bukstein D, Luskin A, Zeitz H: Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma. Ann Allergy Asthma Immunol 1998; 80: 45-49.
3. Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum Huson JA, Huson AP: Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol 1998; 187: 23-42.
4. Korman TM, Turnidge JD, Grayson ML: Neurological complications of chlamydial infections: case report and review. Clin Infec Dis 1997; 25: 847-851.
5. Anttila TI, Lehtinen T, Leinonen M, Bloigu A, Koskela P, Lehtinen M, Saikku P: Serological evidence of an association between chlamydial infections and malignant lymphomas. Br J Haematol 1998; 103: 150-156.
6. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V: Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2; 1988: 983-986.
7. Maass M, Gieffers J: Prominent serological response to Chlamydia pneumoniae in cardiovascular disease. Immunol Inf Dis 1996; 6: 65-70.
8. Ossewaarde JM, Feskens EJ, De Vries A, Vallinga CE, Kromhout D: Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 1998; 120: 93-99.
9. Danesh J, Wong Y, Ward M, Muir J: Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease. Heart 1999; 81: 245-247.
10. Freidank HM, Lux A, Dern P, Meyer-König U, Els T: Chlamydia pneumoniae DNA in peripheral venous blood samples from patients with carotid artery stenosis. Eur J Clin Microbiol Infect Dis 2002; 21: 60-62.
11. Ridker PM, Kundsin RB, Stampfer MJ, Poulin S, Hennekens CH: Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation 1999; 99: 1161-1164.
12. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Wong Y-K, Bernardes-Silva M, Ward M: Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ 2000; 321: 208-213.
13. Danesh J, Whincup P, Lewington S, Walker M, Lennon L, Thomson A, Wong YK, Zhou X, Ward M: Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis. Eur Heart J 2002; 371-375.
14. Boman J, Hammerschlag MR: Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev 2002; 15: 1-20.
15. Speir E, Huang ES, Modali R, Leon MB, Shawl F, Finkel T, Epstein SE: Interaction of human cytomegalovirus with p53: possible role in coronary restenosis. Scand J Infect Dis 1995; 99 (suppl): 78-81.
16. Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, Hammerschlag MR, Jackson LA, Kuo CC, Maass M, Messmer TO, Talkington DF, Tondella ML, Zaki SR: C pnemoniae Workshop Participants. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001; 33: 492-503.
17. Peeling RW, Wang S-P: Chlamydia pneumoniae serology: Interlaboratory variation in microimmunofluorescence assay results. J Infect Dis 2000; 181 (suppl 3): 426-429.
18. Campbell LA, Melgosa MP, Hamilton DJ, Kuo CC, Grayston JT: Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol 1992; 30: 434-439.
19. Wang SP: A micro-immunofluorescence method. Study of antibody response to TRIC organisms in mice. In: Nichols RL (ed): Trachoma and related disorders caused by chlamydial agents. Excerpta Medica, Amsterdam 1971, pp 273-318.
20. Wang SP: Serology for Chlamydia pneumoniae. In: Allegra L, Blasi F (eds): Chlamydia pneumoniae. The lung and the heart. Springer-Verlag Italia, Milan, Italy 1999, pp 16-23.
21. Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, Epstein SE: Association between prior cytomegalovirus infection and risk of restenosis after coronary atherectomy. N Engl J Med 1996; 335: 624-630.
22. Carlsson J, Miketic S, Mueller KH, Brom J, Ross R, von Essen R, Tebbe U: Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty. Lancet 1997; 350: 1225.
23. Zhou YF, Csako G, Grayston JT, Wang SP, Yu ZX, Shou M, Leon M, Epstein ES: Lack of association of restenosis following coronary angioplasty with elevated C-reactive protein levels or seropositivity to Chlamydia pneumoniae. Am J Cardiol 1999; 84: 595-598.
24. Maass M, Giefers J, Krause E, Engel PM, Bartels C, Solbach W: Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients. Med Microbiol Immunol (Berl) 1998; 187: 103-106.
25. Tiran A, Tio RA, Ossewaarde JM, Tiran B, den Heijer P, The TH, Wilders-Truschnig MM: Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies. J Clin Microbiol 1999; 37: 1013-1017.
26. Daus H, Özbek C, Saage D, Scheller B, Schieffer H, Pfreundschuh M, Gause A: Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation. Cardiology 1998; 90: 83-88.
27. Boman J, Gaydos CH, Quinn TC: Molecular diagnosis of Chlamydia pneumoniae infection. J Clin Microbiol 1999; 37: 3791-3799.
28. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT: Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167: 841-849.
29. Maass M, Jahn J, Gieffers J, Dalhoff K, Katus HA, Solbach W: Detection of Chlamydia pneumoniae within peripheral blood monocytes of patients with unstable angina or myocardial infarction. J Infect Dis 2000; 181: 449-451.
30. Ouchi K, Fujii B, Kanamoto Y, Karita M, Shirai M, Nakazawa T: Chlamydia pneumoniae in coronary and iliac arteries of Japanese patients with atherosclerotic cardiovascular diseases. J Med Microbiol 1998; 47: 907-913.
31. Gabriel AS, Gnarpe H, Gnarpe J, Hallander H, Nyquist O, Martinsson A: The prevalence of chronic Chlamydia penumoniae infection as detected by polymerase chain reaction in pharyngeal samples from patients with ischaemic heart disease. Eur Heart J 1998; 19: 1321-1327.
32. Boman J, Allard A, Persson K, Lundborg M, Juto P, Wadell G: Rapid diagnosis of respiratory Chlamydia pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection by EIA. J Infect Dis 1997; 175: 1523-1526.
33. Sessa R, Di Pietro M, Schiavoni G, Santino I, Cipriani P, Romano S, Penco M, del Piano M: Prevalence of Chlamydia pneumoniae in peripheral blood mononuclear cells in Italian patients with acute ischaemic heart disease. Atherosclerosis 2001; 159: 521-525.
34. Wong YK, Dawkins KD, Ward ME: Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease. J Am Coll Cardiol 1999; 34: 1435-1439.
35. Haranaga S, Yamahuchi H, Leparc GF, Friedman H, Yamamoto Y: Detection of Chlamydia pneumoniae antigen in PMNCs of healthy blood donors. Transfusion 2001; 41: 114-119.
36. Mattila KJ, Juvonen JT, Kotamaki MK, Saikku PA: Chlamydia pneumoniae and luminal narrowing after coronary angioplasty. J Intern Med 2001; 250: 67-71.
37. Neumann F, Kastrati A, Miethke T, Pogatsa-Murray G, Mehilli J, Valina C, Jogethaei N, da Costa CP, Wagner H, Schomig A: Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial. Lancet 2001; 357: 2085-2089.